MELISSA WELCH: Open Payments
NPI 1609378868 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 91 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $907 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $253 |
| Lilly USA, LLC | 11 | $244 |
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| PFIZER INC. | 13 | $206 |
| ABBVIE INC. | 11 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Phathom Pharmaceuticals, Inc. | 5 | $98 |
| Esperion Therapeutics, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Dexcom, Inc. | 3 | $69 |
Products named: Wegovy, NURTEC ODT, MOUNJARO, FARXIGA, Kerendia, QULIPTA, VOQUEZNA, NEXLETOL.
Industry payments across FL — which companies pay providers there.
